Ellington Management Group’s CVS Health CVS Stock Holding History

Ellington Management Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,677	Closed	-$857K	–	52
2020 Q3	$857K	Buy	14,677 +4,800	+49%	+$299K	0.3%	35
2020 Q2	$642K	Sell	9,877 -17,973	-65%	-$1.13M	0.27%	34
2020 Q1	$1.65M	Buy	27,850 +2,050	+8%	+$137K	0.39%	39
2019 Q4	$1.92M	Buy	+25,800	New	+$1.81M	0.41%	52
2019 Q3	–	Sell	-14,300	Closed	-$779K	–	627
2019 Q2	$779K	Buy	+14,300	New	+$770K	0.13%	162
2019 Q1	–	Sell	-15,100	Closed	-$989K	–	584
2018 Q4	$989K	Buy	+15,100	New	+$1.13M	0.3%	91
2018 Q2	–	Sell	-8,400	Closed	-$523K	–	572
2018 Q1	$523K	Buy	+8,400	New	+$603K	0.04%	393
2015 Q3	–	Sell	-2,000	Closed	-$210K	–	745
2015 Q2	$210K	Buy	+2,000	New	+$204K	0.05%	580
2013 Q4	–	Sell	-9,500	Closed	-$539K	–	605
2013 Q3	$539K	Buy	9,500 +1,500	+19%	+$89.4K	0.1%	285
2013 Q2	$457K	Buy	+8,000	New	+$463K	0.09%	349

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ellington Management Group's CVS Position: Q4 2020 in Review

Ellington Management Group sold out of CVS Health (CVS) in Q4 2020, closing a stake of 14,677 shares — an estimated $857K sold.

Ellington Management Group first reported a position in CVS in Q2 2013 and held it in 10 quarters. The position peaked at $1.92M in Q4 2019. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

Ellington Management Group reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
Ellington Management Group sold 14,677 CVS Health shares in Q4 2020, an estimated $857K.
Ellington Management Group first reported a position in CVS Health in Q2 2013 and held it in 10 quarters.
Ellington Management Group's CVS Health position peaked at $1.92M in Q4 2019.
1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Ellington Management Group's 13F filing for Q4 2020, filed 16 Feb 2021.